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A B S T R A C T
Actinic reticuloid (AR) or chronic actinic dermatitis is considered a sunlight-induced pseudolymphoma (PSL) on light
exposed areas of the skin, which primarily affects elderly males. The disease is a severe, chronic photosensitive dermatosis,
first described by Ive et al. in 1969. PSL is a group of non-cancerous lymphocytic skin disorders that simulate malignant
lymphomas, but the changes usually spontaneously regress. The clinical appearance of Actinic reticuloid is variable, usu-
ally characterized by an eczematous, pruritic eruption, predominantly present on the head and neck, or other sun exposed
areas, but can involve any area of the body. Thereby, crucial characteristic is photosensitivity, whereat action spectrum in-
volves UVB, UVA and visible light beyond 400 nm. The disease is considered as PSL which histologically resembles lym-
phoma with immunohistochemical analysis of the cutaneous infiltrate revealing presence of activated T cells, numerous
histiocytes, macrophages and B cells. Moreover, the development of malignant (non-cutaneous) T cell lymphoma in the
course of AR has been reported. As the disease has chronic character, it requires significant changes in the patient´s life-
style and avoidance of provoking factors such as contact allergens or sources of intense light. Thus AR should be consid-
ered in every patient who presents with persistent, unclear, erythematous skin changes on the face and neck that are re-
lated to sun exposure.
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Introduction
Skin diseases that affect sun exposed skin and that
are worsening by exposure to light are getting more com-
mon and they present difficult diagnostic and therapeu-
tic problems. It was confirmed that exposure to sun and
ultraviolet (UV) radiation (mostly UVA and UVB) may
have an effect on numerous molecular processes that
damage the skin, causing different skin changes and
diseases1,2. Thereby, we present Actinic reticuloid (AR) as
a rare skin disease, but with increasing prevalence.
Pseudolymphoma
Pseudolymphomas (PSL) are reactive lymphocytic pro-
liferations that appear in the skin and resemble a malig-
nant lymphoma, but changes in PSL usually spontane-
ously regress (as the name says, the term »pseudo« means
»not real«, and »lymphoma« means »a cancerous tumor of
lymphocytes«)3,4. So the important characteristic of the
PSL group is its reversible character. There are different
causes and classifications of PSL, but the diseases are
mostly classified based on their etiological and clinical fea-
tures. Thus, there are various types: Idiopathic type (un-
known cause); Lymphomatoid drug eruption (caused by
systemic drugs); Lymphomatoid contact dermatitis (cau-
sed by topical allergens); Arthropod-induced PSL (caused
by insects or scabies); Actinic reticuloid (caused by sun-
light); Lymphocytoma cutis (caused by Lyme disease, shin-
gles, tattoos, ear-piercing, acupuncture, etc.4
Causes of PSLs differ and include: drugs (topical or
systemic); foreign agents (tattoo dyes, insect bites, sca-
bies, vaccines, hyposensitization injections, trauma, acu-
puncture); infections (Borrelia burgdorferi infection, Ly-
me disease, Herpes zoster); photosensitivity (sensitivity to
UV light); idiopathic (unknown causes). There are various
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drugs reported to cause PSL of the skin: anticonvulsants;
antipsychotics (chlorpromazine, thioridazine); antihyper-
tensives (captopril, atenolol, verapamil, diltiazem, modu-
retic, hydrochlorothiazide); cytotoxics (cyclosporine, me-
thotrexate); antirheumatics (gold, salicylates, phenacetin,
D-penicillamine, allopurinol); antibiotics (penicillin, ni-
trofurantoin); antidepressants: fluoxetine, doxepin, desi-
pramine, amitriptyline hydrochloride, lithium); anxiolyt-
ics (alprazolam, clonazepam, lorazepam); antihistamines
(diphenhydramine, cimetidine, ranitidine); antiarrhyth-
mics (mexiletine chloride), etc.4. However, the cause of
PSL is not always known, as in the idiopathic type or in
lymphomatoid papulosis.
All of these dermatoses usually affect young adults (25
to 40 years old) and are generally more common in fe-
males, except in the case of AR which mostly affects el-
derly males4. The group of PSLs also tends to be much
more prevalent in Caucasians.
Clinical appearance of PSL is variable and is usually
characterized by patches and plaques located on the head
and neck, although any area of the body can be involved.
They may be single or multiple, small or large, red to pur-
ple, doughy or firm. Patients with PSL may also present
with a rash involving the entire body or with lesions lo-
cated at the sites of trauma. The patients often complain
of itch, which can sometimes be intense, especially in
those who have lymphoid contact dermatitis, insect bites,
scabies or AR.
Diagnosis of PSL requires a complete medical history
and physical examination, followed by pathohistological
analysis. In the diagnostics of PSL, skin biopsy is crucial,
but laboratory parameters may also be examined. Some-
times a diagnostic dilemma appears, especially in the dif-
ferentiation of PSL from malignant lymphoma, whih is of
great importance, as the clinical course and therapeutic
options are quite different4.
Although the treatment depends on the type of PSL,
mostly used are topical steroids (sometimes intralesional).
It is important to remove possible causative agents and to
avoid precipitating factors. Other therapy includes topical
sunscreens, systemic antibiotics, local radiation, PUVA
therapy, cytotoxic agents and other.
The course of PSL is variable as the disease lasts for a
period of a few weeks to years. In general, PSLs eventu-
ally resolve either spontaneously or following the removal
of the causative agent. It is important that patients with
PSL have close follow-ups, especially in persistent and re-
sistant cases, due to the possible association with malig-
nant lymphoma4.
Characteristics of Actinic reticuloid
Actinic reticuloid is a chronic persistent photosensi-
tive dermatosis, first described by Ive and co-workers in
19695,6. The disease is considered a sunlight-induced PSL
which predominantly occurs in elderly men as pruritic
infiltrated skin changes, papules and plaques on exposed
parts with occasional extension to covered areas and
rarely associated with episodes of erythroderma7. Al-
though AR particularly affects men over the age of 50, it
also arises in women and is increasingly found in young,
male and female patients, with atopic dermatitis.
Although the clinical pattern of AR is similar to that
of persistent light reaction, histologically AR often inclu-
des cytologic atypia of lymphocytes, resembling Mycosis
fungoides. The phrase »reticuloid« suggests that it is a
pseudomalignancy (similar to lymphoma), yet in a few
instances, patients develope genuine lymphomas.
It may be mentioned that for this dermatosis there
are different synonyms: chronic actinic dermatitis (CAD),
persistent light reaction, photosensitivity dermatitis/ac-
tinic reticuloid syndrome (PD/AR)4. Currently the most-
ly used term for this dermatosis is chronic actinic derma-
titis. We consider that the term AR is also suitable, since
the disease doesn't include only actinic skin changes, but
also has histological characteristics of PSL and some-
times even those of lymphoma. Namely, histologically
and immunohistochemical analysis of the cutaneous in-
filtrate mostly reveales activated T cells, numerous his-
tiocytes, macrophages and B cells. Most of the lympho-
cytes express a phenotype of suppressor T cells (CD8+)7.
In the etiopathogenesis, photosensitivity to both UVA
and UVB, as well as to visible light beyond the wave-
length of 400 nm is a crucial characteristic3.
History of Actinic reticuloid
In 1969 Ive et al. first described AR as a condition of
elderly males characterized by erythematous thickening
of light-exposed areas of the skin with formation of
plaques, accentuation of skin creases, and often episodes
of generalized erythroderma5,8. On the other hand, the
term chronic actinic dermatitis was first proposed by
Hawk andMagnus in 1979 to unify the conditions known
as Persistent light reactivity (Wilkinson, 1961), AR (Ive et
al., 1969), Photosensitive eczema (Ramsay and Black, 1973),
and Photosensitivity dermatitis (Frain-Bell et al., 1974)9.
Previously in 1973, Ramsay & Kobza Black proposed
a new entity called Photosensitive eczema, which had
clinical features of eczema limited predominantly to light
exposed areas. Etiopathogenically, photosensitivity was
emphasized as crucial and the irradiation monochroma-
tor findings showed abnormalities confined to the short
wavelength UV (300–340 nm)., It has been observed that
photopatch tests may be negative, but patch tests often
show positive results8.
In 1974 Frain-Bell et al. pointed out that cases with
irradiation monochromator abnormalities (extending
from the short into the long wavelength UV) may have a
clinical and histological appearance of photosensitive ec-
zema or that of AR and questioned whether there is a
clear distinction between these two conditions8.
Generally, the three main criteria of AR (CAD) is re-
duction in the minimal erythema dose to UVA, UVB
and/or visible light; persistent eczematous eruption pre-
dominantly on sun-exposed skin, sometimes extending to
covered areas; and histopathologic changes consistent
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with chronic eczema with or without cutaneous lym-
phoma-like changes9.
It is also necesarry to mention that ARmay occur after
endogenous eczema, photoallergic or allergic contact der-
matitis, oral drug photosensitivity, occasionally polymor-
phic light eruption and rarely following HIV infection9.
Clinical and histological picture of
Actinic reticuloid
The clinical picture of AR is characterised by an ec-
zematous, pruritic eruption, predominantly present on
light exposed areas of the skin. The initial symptom is
persistent erythema of the face, with subsequent devel-
opment of an eczematous, patchy or diffuse, pruritic, of-
ten lichenified eruption on sun-exposed areas. The chan-
ges are particularly common on the face, the scalp, the
V-area of the chest, on the back, the sides of the neck and
on dorsal aspects of hands and forearms, often with
sharp demarcation at the lines of clothing9. Patients may
have palmar and plantar eczema, loss of eyebrows and
scalp hair, occasionally erythroderma, as well as other
changes. The erythrodermic variant of AR can resemble
Sezary syndrome (a type of cutaneous T cell lymphoma –
CTCL, with the presence of atypical lymphocytes in pe-
ripheral blood)6.
It is also important to mention that some affected pa-
tients with AR may not complain of abnormal reactions
to sunlight because they may be so sensitive to UVA and
visible wavelengths, which penetrate window glass, that
no relationship to sunlight exposure is noticed9.
Histologically, AR is characterized by the presence of
extensive dermal, predominantly perivascular, mononuc-
lear-cell infiltrates, occasionally with large hyperchro-
matic convoluted nuclei and mitotic figures9. Those pre-
dominantly lymphocytic infiltrates show in some instan-
ces marked atypia, but progression to lymphoma is most
uncommon10. The infiltrating cells show epidermotro-
pism and sometimes even form Pautrier-like microab-
cesses6. Other histological changes include epidermal
spongiosis, acanthosis, dermal fibrosis, sometimes with
hyperplasia. Other cells include macrophages, eosino-
phils and plasma cells9. Generally, the histological fea-
tures are similar to those characteristic of Mycosis fun-
goides (the most common variant of CTCL) and Sezary
syndrome6,10. However, it was confirmed that AR has a
characteristic immunophenotype distinct from most ca-
ses of CTCL, with CD8+ cells in the epidermis and dis-
cordance between BF1 (b-chain constant region of T-cell
receptor) cells and CD3 expression6. Because of the clini-
cal and histological similarities between AR and CTCL
and in particular, the presence of atypical T cells with
cerebriform nuclei in the skin and peripheral blood, dif-
ferentiating between these two diseases can be extremely
difficult. Moreover, the development of malignant (non-
-cutaneous) TCL in the course of AR has been reported.
Generally, the presence of a predominantly CD8+ T cell
population in skin infiltrates or demonstration of an in-
creased proportion of CD8+ T cells and a reversed CD4:
CD8 ratio in peripheral blood have been considered as
useful additional criteria favouring a diagnosis of AR
rather than CTCL6. However, some AR patients may
demonstrate predominantly CD4+ T cell skin infiltrates,
indicating that the immunophenotypic criteria cannot be
relied on in all cases. Some studies demonstrated that
morphometric analysis (nuclear contour indexing) of cir-
culating atypical T cells may also contribute to the differ-
entiation between AR and Sezary syndrome6,11.
Pathogenesis of Actinic reticuloid
Although the cause of AR (CAD) is not known, it is
suspected that the body’s defence system overreacts to
substances within the skin that are made ‘allergic’ by
UV and visible light. This corresponds to the crucial
characteristic of AR – photosensitivity, i.e. hypersensitiv-
ity to UVB, UVA and visible light beyond 400 nm. One
theory has proposed that during an initial photoallergic
reaction, a normal skin constituent is altered to become
antigenic. Induction begins with UVA-dependent cova-
lent binding of hapten to an endogenous protein and is
followed by a delayed-type hypersensitivity response (ty-
pe IV). As the disease progresses to AR, UVB and UVA
alone may trigger the immune response without the
hapten by continuing to form the antigenic photoproduct
from the endogenous carrier protein9.
So diagnostic procedures, besides histopathological
examination, include phototesting that uses specialised
equipment which is accessible in some university derma-
tology centres. Phototesting consists of having areas of
skin exposed to known amounts of light of specific wave-
lengths, observing thereafter skin reactions with com-
parison to the response of the average population. Pho-
totests to UV and often visible irradiation (this reaction
peaks inbetween 7 and 24 hours following exposure) may
show erythematous or eczematous reactions, usually at
doses much lower than the normal minimal erythema
dose. The provoking wavelengths are UVB (280–320
nm), virtually in all patients, UVA (320–400 nm) in most
patients, and visible light or UVA alone in only a few
patients9.
Recent examination of AR has also confirmed delayed
type hypersensitivity response (type IV)9. Histological
and immunohistochemical analysis of lesions have con-
firmed increased ICAM-1 expression and a dermal infil-
trate of predominantly CB8+ T cells, suggesting type IV
response which is characteristic of contact allergy. It is
also proven that allergic and/or photallergic contact der-
matitis commonly coexist with AR and often precedes the
onset of photosensitivity. The analysis of testing AR
(CAD) patients (89 patients) by patch or photopatch tests
showed positive results in 74% patients. Thereby, patch
test was positive to sesquiterpene lactone mix in 36%, to
fragrance compounds in 21%, to colophony in 20% and to
rubber chemicals in 14%. On the other hand, the analysis
of photopatch test results showed 6% patients positive to
musk ambrette, 7% to sunscreens, and one to both9.
Thereby, the majority of AR patients have allergies to
some substances which come into contact with their
skin, particularly various flowers, types of wood, per-
L. Lugovi}-Mihi} et al.: Actinic Reticuloid, Coll. Antropol. 35 (2011) Suppl. 2: 325–329
327
fumes, sunscreens and rubber compounds. Patch testing
to determine contact allergens is therefore useful in such
patients and is conducted by most dermatologists.
Therapy for Actinic reticuloid
The mainstay of AR treatment is sunlight avoidance
(protective clothing, non-irritating broad-spectrum sun-
screens, filters for home and car windows) and, when ap-
plicable, allergen avoidance9. The most commonly used
steroid creams/ointments are useful in the acute stage of
the disease but are generally only partially effective (po-
tent varieties should be used only in the short term). The
use of topical tacrolimus ointment may also be of benefit.
Treatment for resistant disease includes low-dose PUVA,
narrow-band UVB, cyclosporine, azathioprine, systemis
steroids (short time) and mycophenolate mofetil alone or
in combination9. Thus, there are also good results with
UVB in combination with prednisolone, azathioprine,
B-carotene, hydroxychloroquine and cyclosporine7.
Many patients with AR are spontaneously cured, which
may take up to several years. According to results of a
clinical study, resolution of photosensitivity within 10
years occurred in some 20% of patientes9. It was also
shown that a severely abnormal UVB photosensitivity
and positive polyvalent patch tests are predictors of a
poorer prognosis. In such cases, there is usually a persis-
tence of contact allergy, despite an eventual clinical im-
provement of photosensitivity9.
It is necessary for the patients to have sufficiant in-
formation about their disease and to learn to live with
the condition, managing it by minimising exposure to UV
and visible light, as well as to contact allergens. Accord-
ing to their photosensitivity which involves non-sunburn
wavelengths of light (longwave UV and visible light
wavelengths), patients may develop skin changes even
on cloudy days. Such patients have to be aware of the fact
that clothing and windows offer for them often no real
protection (unless the clothing totally blocks the light
out). There is good evidence that this condition will com-
pletely clear in a number of patients without the need for
therapy, although this may take many years.
Conclusion
AR is a term describing a nonspecific and overlapping
appearance that encompasses multiple features, includ-
ing that of photosensitivity and PSL characteristics. As
the disease is chronic in nature, it requires significant
changes in the patient´s lifestyle and avoidance of pro-
voking factors, including contact allergens and sources of
intense light. AR should therefore be considered in every
patient who presents with persistent, unclear, erythema-
tous skin changes on the face and neck that are related to
sun exposure.
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AKTINI^KI RETIKULOID – FOTOSENZITIVNOST ILI PSEUDOLIMFOM?
S A @ E T A K
Aktini~ki retikuloid (AR) ili kroni~ni aktini~ki dermatitis se smatra sun~evom svjetlo{}u induciranim pseudolimfo-
mom (PSL) na podru~jima ko`e izlo`enima svjetlosti, koji primarno poga|a starije mu{karce. Bolest je te{ka, kroni~na
fotosenzitivna dermatoza, prvi puta opisana od Ive i sur. 1969. PSL je grupa nekanceroznih limfocitnih poreme}aja ko`e
koji opona{aju maligne limfome, ali se promjene obi~no spontano povla~e. Klini~ka slika AR je varijabilna, obi~no obilje-
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`ena ekcematoznom, pruriti~nom erupcijom poglavito prisutnom na glavi i vratu ili na drugim podru~jima izlo`enima
suncu, ali mo`e zahvatiti bilo koje podru~je tijela. Stoga je klju~na osobina fotosenzitivnost, pri ~emu raspon djelovanja
obuhva}a UVB, UVA i vidljivu svjetlost iznad 400 nm. Bolest se smatra pseudolimfomom koji histolo{ki nalikuje lim-
fomu uz nalaze imunohistokemijske analize infiltrata u ko`i koji otkrivaju prisutnost aktiviranih T stanica, brojne
histiocite, makrofage i B stanice. [tovi{e, opisan je nastanak malignog (ne-kutanog) T stani~nog limfoma u tijeku AR.
Budu}i da bolest ima kroni~ni karakter, zahtijeva zna~ajne promjene u bolesnikovu na~inu `ivota i izbjegavanje provo-
ciraju}ih ~imbenika poput kontaktnih alergena ili izvora intenzivne svjetlosti. Stoga AR treba uzeti u obzir kod svakog
bolesnika koji pokazuje perzistentne, nejasne, eritematozne promjene ko`e na licu i vratu, a koje su povezane s izla-
ganjem suncu.
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